Table 3.
Relationship between CD8+ iTILs and clinicopathological factors
| Clinicopathological factors | CD8+ iTILs | P value | ||
|---|---|---|---|---|
|
| ||||
| Low | High | |||
| Gender | Male | 29 | 28 | 0.620 |
| Female | 15 (34.1%) | 18 (39.1%) | ||
| Age | ≤ 60 years | 21 | 21 | 0.844 |
| > 60 years | 23 (52.3%) | 25 (54.3%) | ||
| Pathologic differentiation | High | 27 | 32 | 0.413 |
| Low | 17 (38.6%) | 14 (30.4%) | ||
| Tumor size | ≤ 4 cm | 26 | 25 | 0.650 |
| > 4 cm | 18 (40.9%) | 21 (45.7%) | ||
| Nerve invasion | Negative | 24 | 29 | 0.413 |
| Positive | 20 (45.5%) | 17 (37.0%) | ||
| Lymphatic vessel invasion | Negative | 22 | 35 | 0.010 |
| Positive | 22 (50.0%) | 11 (23.9%) | ||
| Stage (I vs II + IV) | I | 13 | 27 | 0.005 |
| II + IV | 31 (70.5%) | 19 (41.3%) | ||